acquire-immunity Downloads
1 downloads found
With Novartis creating Borealis Biosciences and gaining approval for their IgAN therapy along with Travere Therapeutics, Otsuka’s success in phase III interim analysis, Apellis and Sobi’s phase III trial success, Judo Bio launching with $100M, Biogen acquiring HIBio for $1.15B, Vertex acquiring Alpine Immune Sciences for $4.9B and the FDA’s support of accelerated pathways for ...